brimonidine tartrate has been researched along with Hypertension in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 12 (46.15) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Boualila, L; Bouirig, K; Boutimzine, N; Cherkaoui, LO; El Hamidi, S | 1 |
| Campagna, O; Colica, C; Cruciani, F; De Vico, U; Gharbiya, M | 1 |
| Ames, R; Farias, AA; Sandhu, G | 1 |
| Begaye, M; Carter, RW; Kanagy, NL | 1 |
| Carter, RW; Kanagy, NL | 1 |
| Dina, JP; Feres, T; Paiva, AC; Paiva, TB | 1 |
| Nishio, I; Tsuda, K; Tsuda, S | 1 |
| de Villiers, AS; Jaffer, A; Russell, VA; Sagvolden, T; Searson, A; Taljaard, JJ | 1 |
| Bohmann, C; Rump, LC; Schaible, U; Schollmeyer, P | 1 |
| Albino-Teixeira, A; Guimarães, S; Moura, D; Paiva, MQ; Vaz-da-Silva, MJ | 1 |
| García-Sevilla, JA; Miralles, A; Ribas, C | 1 |
| Bohmann, C; Rist, W; Rump, LC; Schollmeyer, P | 1 |
| Beenen, OH; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA | 2 |
| Li-Bo, Z; Matsuda, K; Sekiguchi, F; Shimamura, K; Sunano, S; Watanabe, H | 1 |
| Kanagy, NL | 1 |
| Borges, AC; Feres, T; Paiva, AC; Paiva, TB; Silva, EG | 1 |
| Borea, PA; Caiazza, A; Gessi, S; Portaluppi, F; Rastelli, G; Varani, K | 1 |
| Borea, PA; Caiazza, A; Gessi, S; Manfredini, R; Portaluppi, F; Varani, K | 1 |
| Fechtner, RD | 1 |
| Allie, S; Russell, V; Wiggins, T | 1 |
| Herzer, WA; Jackson, EK; Kost, CK; Vyas, SJ | 1 |
| Kanagy, NL; Mukundan, H | 1 |
| Goldstein, M; Masuyama, Y; Nishio, I; Tsuda, K; Tsuda, S | 1 |
| Fernandez-Roman, M; Fuentes, JA; Naranjo, JR; Urdin, MC | 1 |
1 review(s) available for brimonidine tartrate and Hypertension
| Article | Year |
|---|---|
Brimonidine induced bilateral hypertensive anterior uveitis: Case report and review of the literature.
Topics: Brimonidine Tartrate; Humans; Hypertension; Uveitis; Uveitis, Anterior | 2023 |
1 trial(s) available for brimonidine tartrate and Hypertension
| Article | Year |
|---|---|
Platelet alpha2-adrenoceptor alterations in patients with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Blood Platelets; Brimonidine Tartrate; Colforsin; Cyclic AMP; Epinephrine; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypertension; Male; Middle Aged; Protein Binding; Quinoxalines; Receptors, Adrenergic, alpha-2; Thermodynamics | 1999 |
24 other study(ies) available for brimonidine tartrate and Hypertension
| Article | Year |
|---|---|
INN Common stem: -onidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Antimalarials; Brimonidine Tartrate; Cinchona Alkaloids; Clonidine; Humans; Hypertension; Imidazoles; Ocular Hypertension; Rilmenidine; Rosacea; Terminology as Topic | 2017 |
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Hypertension; Miotics; Mydriasis; Ocular Hypertension; Pilocarpine; Prostaglandins F; Quinoxalines; Sulfonamides; Syndrome; Thiophenes; Timolol | 2013 |
Pseudopheochromocytoma secondary to brimonidine ophthalmic solution.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Diagnosis, Differential; Female; Humans; Hypertension; Pheochromocytoma; Quinoxalines | 2010 |
Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta.
Topics: Adrenergic alpha-Agonists; Amides; Animals; Aorta; Brimonidine Tartrate; Enzyme Inhibitors; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Penicillamine; Protein Serine-Threonine Kinases; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; rho-Associated Kinases; rhoA GTP-Binding Protein; Vasoconstriction | 2002 |
Tyrosine kinases regulate intracellular calcium during alpha(2)-adrenergic contraction in rat aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta; Brimonidine Tartrate; Calcium; Enzyme Inhibitors; Flavonoids; Hypertension; Male; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Quinazolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tyrphostins | 2002 |
Role of membrane potential and expression of endothelial factors in restenosis after angioplasty in SHR.
Topics: Adrenergic alpha-Agonists; Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Brimonidine Tartrate; Carotid Arteries; Endothelin-1; Endothelium, Vascular; Hypertension; In Vitro Techniques; Male; Membrane Potentials; Nitric Oxide; Peptides; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Wistar | 2004 |
Role of alpha2-adrenergic receptors and cyclic adenosine monophosphate-dependent protein kinase in the regulation of norepinephrine release in the central nervous system of spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Central Nervous System; Clonidine; Cyclic AMP-Dependent Protein Kinases; Electric Stimulation; GTP-Binding Protein alpha Subunits, Gi-Go; Hypertension; Isoquinolines; Male; Medulla Oblongata; Norepinephrine; Pertussis Toxin; Presynaptic Terminals; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 2003 |
Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Biogenic Monoamines; Brimonidine Tartrate; Disease Models, Animal; Dopamine; Hypertension; In Vitro Techniques; Male; Neurons; Norepinephrine; Nucleus Accumbens; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-2; Tritium | 1995 |
Alpha 2D-adrenoceptors modulate renal noradrenaline release in normotensive and spontaneously hypertensive rats.
Topics: Animals; Binding Sites; Blood Pressure; Brimonidine Tartrate; Electric Stimulation; Hypertension; Kidney; Norepinephrine; Perfusion; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-2 | 1994 |
Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Arteries; Brimonidine Tartrate; Hypertension; Male; Neuroeffector Junction; NG-Nitroarginine Methyl Ester; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P1; Tail; Xanthines | 1994 |
Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Brimonidine Tartrate; Cerebral Cortex; Clorgyline; Dioxanes; Down-Regulation; Hypertension; Idazoxan; In Vitro Techniques; Kinetics; Male; Membranes; Quinolines; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Species Specificity | 1993 |
Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brimonidine Tartrate; Dioxanes; Dose-Response Relationship, Drug; Hypertension; Idazoxan; Imidazoles; Kidney; Methoxamine; Perfusion; Prazosin; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasoconstriction | 1995 |
Opposite influences of hypertension and diabetes mellitus on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed rats.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Azepines; Blood Glucose; Blood Pressure; Brimonidine Tartrate; Clonidine; Decerebrate State; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypertension; Imidazoles; Male; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Influence of nifedipine on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed diabetic hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brimonidine Tartrate; Calcium; Calcium Channel Blockers; Clonidine; Diabetes Mellitus, Experimental; Hypertension; Imidazoles; Nifedipine; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin | 1996 |
Endothelium-dependent relaxation by alpha 2-adrenoceptor agonists in spontaneously hypertensive rat aorta.
Topics: Acetylcholine; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Aorta; Brimonidine Tartrate; Endothelium, Vascular; Hypertension; Indomethacin; Nitroarginine; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2; Vasodilation | 1996 |
Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Brimonidine Tartrate; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; Mesenteric Artery, Superior; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Phenylephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Systole; Vasoconstriction; Yohimbine | 1997 |
Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apamin; Biological Factors; Brimonidine Tartrate; Endothelium, Vascular; Enzyme Inhibitors; Female; Hypertension; In Vitro Techniques; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Prazosin; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-2 | 1998 |
Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Platelets; Brimonidine Tartrate; Case-Control Studies; Cell Membrane; Doxazosin; Female; Humans; Hypertension; In Vitro Techniques; Kinetics; Male; Middle Aged; Propranolol; Quinoxalines; Receptors, Adrenergic, alpha-2 | 2000 |
Initial medical management of open-angle glaucoma.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Hypertension; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Quinoxalines | 2000 |
Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Attention Deficit Disorder with Hyperactivity; Brimonidine Tartrate; Disease Models, Animal; Dopamine; Down-Regulation; Hypertension; Idazoxan; In Vitro Techniques; Male; Models, Neurological; Norepinephrine; Prefrontal Cortex; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Long-Evans; Receptors, Adrenergic, alpha-2 | 2000 |
Enhanced interaction between renovascular alpha(2)-adrenoceptors and angiotensin II receptors in genetic hypertension.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Brimonidine Tartrate; Captopril; Hypertension; Male; Methoxamine; Nephrectomy; Protein Binding; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Angiotensin; Renal Artery; Renal Circulation; Species Specificity; Vascular Resistance; Vasoconstrictor Agents | 2001 |
Ca2+ influx mediates enhanced alpha2-adrenergic contraction in aortas from rats treated with NOS inhibitor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Enzyme Inhibitors; Hypertension; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide Synthase; Nitroarginine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Vasoconstriction | 2001 |
Modulation of noradrenergic transmission by neuropeptide Y and presynaptic alpha 2-adrenergic receptors in the hypothalamus of spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Electric Stimulation; Hypertension; Hypothalamus; In Vitro Techniques; Male; Neuropeptide Y; Norepinephrine; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Synaptic Transmission | 1992 |
Beta-endorphin: a common factor in the antihypertensive action of clonidine-type imidazolines in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; beta-Endorphin; Blood Pressure; Brimonidine Tartrate; Clonidine; Dose-Response Relationship, Drug; Endorphins; Hypertension; Imidazoles; Injections, Intraventricular; Male; Quinoxalines; Rats | 1985 |